|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| C07K 14/47 | (2006.01) |
| (11) | Number of the document | 2565201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12172030.4 |
| Date of filing the European patent application | 2006-10-17 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 726608 P | 2005-10-17 | US | |
| 728304 P | 2005-10-20 | US |
| (72) |
Scheinberg, David A., US
Pinilla-Ibarz, Javier, US
May, Rena, US
|
| (73) |
Sloan-Kettering Institute for Cancer Research,
1275 York Avenue, New York, New York 10021,
US
|
| (54) | WT1 HLA class II-binding peptides and compositions and methods comprising same |
| WT1 HLA class II-binding peptides and compositions and methods comprising same |